Services for pharmaceutical, medical device and ivd, food, feed and cosmetic companies
Medfiles supports its clients on the path of commercialisation with an array of services related to human and veterinary medicines, medical devices and in vitro diagnostic devices and food & feed and cosmetics. We assist our clients at all stages of the product lifecycle.
Our services cover strategic consultation and the entire product development process, starting with pharmaceutical development with quality control laboratory analyses (chemical and microbiological), implementing clinical trials (phases I to IV) and dealing with regulatory affairs (e.g. marketing authorisation, pharmacovigilance). Our one-stop service package offers a fluent and flexible solution for our clients’ outsourcing needs, for businesses of all sizes.
Learn more about Our Services
Client experience is at the heart of everything we do
Why Medfiles?
Over 35 years of experience in pharmaceutical and other healthcare industry. Proven track record and long-standing client relationships.
One-stop service provider – comprehensive services and tailored solutions for every client. We serve companies of all sizes, from start-ups to multinational corporations.
Not too big – not too small. Worktime and resources are organised to ensure maximum efficiency, without ever compromising our values – flexibility, reliability, fairness.
Contact us
Our clients:
NEws and events
A team of 14 experts ensures high-quality regulatory and pharmacovigilance services in the Baltic countries
18.03.2024
Free webinar: EU Veterinary Medicinal Products Regulation from the perspective of variations and the quality part of the pharmacovigilance system
12.03.2024
Planning an investigator-initiated study (IIS)? 10 tips for a successful outcome
11.03.2024
Global pharma company & Medfiles: Cooperation in obtaining and maintaining marketing authorisations in the EU
08.03.2024
Bimeda & Medfiles: a decade of partnership in veterinary regulatory affairs in the EU
07.03.2024
For novel food ingredients, the faster EU market access is to sell them first as feeds and cosmetics
28.02.2024